Ostara is Named in the 2014 Global Cleantech 100 for 6th

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Ostara is Named in the 2014 Global Cleantech 100 for 6th Straight year: Recognized as Market Leader in Waste to Wealth Technology

VANCOUVER, BC, Oct. 8, 2014 (GLOBE NEWSWIRE) -- Ostara Nutrient Recovery Technologies Inc., has been recognized for the 6th straight year as a leader in the clean tech industry for the commercialization of proprietary nutrient recovery technology that recovers nutrients from used water streams to convert them into high value eco-friendly fertilizer. Named in the prestigious 2014 Global Cleantech 100 , produced by Cleantech Group , whose mission is to connect corporates to sustainable innovation through the i3 market intelligence platform , expert consulting services, and global events, expert Global Cleantech panelists praised Ostara Nutrient Recovery Technologies for, "cleverly combining wastewater treatment with the production of a revenue-generating green fertilizer".

The Global Cleantech 100 represents the most innovative and promising ideas in cleantech. Featuring companies that are best positioned to solve tomorrow's clean technology challenges, Global Cleantech 100 is a comprehensive list of private companies with the highest potential to make the most significant market impact.

"It is a thrill to be named to the Global Cleantech 100 list for the 6th consecutive year," said Phillip Abrary, Ostara's president and CEO. "Phosphorus management is one of the most critical resource issues the world faces today. Though essential to all life, and a key macronutrient used to grow the food we need, phosphorus in excess can have negative consequences in our environment causing algae blooms that destroy marine life and wreak havoc on fishery and tourism industries. We are proud to be one of the first companies to address this issue sustainably – both environmentally and economically – by recovering phosphorus and nitrogen from wastewater streams and converting it into plant-activated, environmentally friendly fertilizer sold as Crystal Green®."

This list is collated by combining proprietary Cleantech Group research data, with weighted qualitative judgments of hundreds of nominations, and specific inputs from a global 84-person Expert Panel. To qualify for the list, companies must be independent, for-profit, cleantech companies that are not listed on any major stock exchange.

"The Global Cleantech 100 represents the most inspiring array of entrepreneurs across the cleantech space that are at the forefront of innovation," said Sheeraz Haji, Cleantech Group's CEO. "It is a true honor to gather with the global cleantech community every year to recognize and celebrate the achievements of each of the top 100 companies as they continue to solve tomorrow's energy and resource challenges and redefine sustainable innovation."

This year, a record number of nominations were received: 5,995 distinct companies from 60 countries. These companies were weighted and scored to create a short list of 327 companies. Short-listed nominees were reviewed by Cleantech Group's Expert Panel, resulting in a finalized list of 100 companies from 17 countries.

Ostara's nutrient recovery process is part of the solution to both wastewater and nutrient runoff challenges – removing nutrients from where they shouldn't be – in waterways – and recovering them to create a new standard of phosphorus fertilizer. Ostara's innovative cradle-to-cradle solution has the potential to impact global markets at a time when food security, fertilizer runoff and environmental stewardship are issues for communities everywhere.

The 84-member expert panel was drawn equally from leading financial investors and representatives of multi-national corporations and industrials active in technology and innovation scouting across Asia, Europe, and North America. The composition of the expert panel broadly represents the global cleantech community, from pioneers and leaders to veterans and new entrants. The diversity of panelists results in a list of companies that command an expansive base of respect and support from many important players within the global cleantech innovation ecosystem.

"The Global Cleantech 100 each year provides us with invaluable insight into which companies key market players think are most likely to have a significant impact in the next 5-10 years," said Richard Youngman, Cleantech Group's Managing Director, Europe & Asia and creator of the program. "How the composition of the Global Cleantech 100 list changes over time is revealing of key megatrends and hot sub-sectors – and helps us all get a view on the future."

About Ostara Nutrient Recovery Technologies

Vancouver-based Ostara helps protect precious water resources by changing the way cities around the world manage nutrients in wastewater streams. The company's Pearl technology recovers phosphorus and nitrogen at municipal and industrial wastewater treatment plants and transforms them into a high-value, eco-friendly fertilizer, Crystal Green®. The process greatly reduces nutrient management costs and helps plants meet increasingly stringent discharge limits while improving operating reliability. Crystal Green is marketed through a global network of blenders and distributors to growers in the turf, horticultural and agriculture sectors. Its unique plant-activated mode of action improves crop yields, enhances turf performance and significantly reduces the risk of leaching and runoff, thus protecting local waterways from the nutrient pollution. Ostara operates facilities throughout North America and Europe and recently partnered with the City of Chicago to build what will be the largest municipal nutrient recovery facility in the world when launched in 2015. The company is the recipient of numerous awards including a World Economic Forum 2011 Technology Pioneer, the Global Cleantech 100 and Deloitte's Technology Green 15. For more information please visit www.ostara.com and www.crystalgreen.com .

PRESS CONTACT

Ostara Nutrient Recovery Technologies
Anthony Boone | 604-367-8062 | aboone@ostara.com

About Cleantech Group  

Founded in 2002, Cleantech Group's mission is to accelerate sustainable innovation. Core to this mission is i3, an online platform that connects corporates with innovation, at scale, by allowing them to find, vet, and connect with start-ups — efficiently building an innovation pipeline. In conjunction with i3, we offer premium Advisory Services for corporates in need of expertise designing and executing strategies for sustainable innovation, and managing the pipeline created in i3. The i3 platform comes to life at our global Events, which convene corporates and start-ups, along with other players shaping the future of sustainable innovation.

Cleantech Group is headquartered in San Francisco, and has offices in London and New York.

For more information, visit; www.cleantech.com

PRESS CONTACT:

Cleantech Group
Yvette Shirinian  | 415-233-9712  | yvette.shirinian@cleantech.com

A photo accompanying this release is available at: http://www.globenewswire.com/newsroom/prs/?pkgid=28263

Ostara Nutrient Recovery Technologies Anthony Boone | 604-367-8062 |

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Stephanie L. Beiermann Shines in HR Consulting Honors

Updated Category News Views 114

Celebrating a Star in Payroll Optimization Ah, the name Stephanie L. Beiermann’s been making the rounds lately, catching eyes with her lauded expertise in payroll optimization and human resources. This recognition doesn’t come out of thin air—no, it’s anchored on a solid foundation of over 25 years of cutting through the fluff to sharpen operational edges. We’re...

Continue Reading
AvidXchange Acquisition Faces Fairness Investigation

Updated Category News Views 317

Unpacking the AvidXchange Turmoil Staring at the ticker tape feels like watching a drama unfold, and today it's all about AvidXchange Holdings, Inc. (NASDAQ: AVDX). Levi & Korsinsky, LLP has launched an investigation into the fairness of its acquisition, and let me tell you, when the suits start poking around, it means someone smells a rat. The deal in question? A buyout...

Continue Reading
Snowhawk Enters Telarus as Digital Demand Gets Serious

Updated Category News Views 7

Telarus just pulled another serious capital partner into the room, and that matters more than the usual law-firm victory lap. Snowhawk Partners has invested in the technology services distributor alongside Columbia Capital, which remains a long-standing partner. Nobody disclosed a valuation, ownership percentage, financing mix, or closing date. Annoying? Sure. But the...

Continue Reading
Lecanemab Shines in 5-Year Alzheimer's Study at CTAD

Updated Category News Views 172

Latest Lecanemab Results Turn Heads at CTAD 2026 The whispers buzzing out of the CTAD 2026 conference are about something promising for those in the trenches of Alzheimer's research: lecanemab. Yep, it's a name that's been bandied about before, and this time it's the long-term data doing the talking. The five-year results from Eisai and Biogen's lecanemab study are...

Continue Reading
Giovanni Recalde Sues County After False Report

Updated Category News Views 215

Justice and Reputation: A Mix-Up Costs Big When the cops screw up, sometimes they really take the cake. That's what Giovanni Recalde learned, the hard way, when his name got tangled in a mess related to a gambling operation he wasn't even a part of. Prince William County police pasted his name into their daily incident report last year like it was no big deal. But it...

Continue Reading
Amdocs Faces a Storm: Investor Alert as Legal Probe Begins

Updated Category News Views 64

Amdocs' Recent Crisis: What Investors Need to Know Lately, it seems Amdocs Limited (NASDAQ: DOX) has found itself knee-deep in a situation that could make seasoned investors cringe. November shone some harsh light on the company's operations, a move that’s attracted attention from Schall, Brown & Schwartz LLP (“SBS”), a name not exactly foreign to shareholder...

Continue Reading
OREF Opens $185,000 Research Grant Funding Cycle Today

Updated Category News Views 66

A hundred grand aimed at better graft science is not pocket change, but it is not a finished clinical program either. That distinction matters with the Orthopaedic Research and Education Foundation's newly opened $185,000 grant cycle. This is targeted, early-to-midstream research support: the sort of money that can produce usable data, sharpen a clinical question, and...

Continue Reading
Armada Moves up as Key Player in US SI Exports

Updated Category News Views 207

Pioneering New Grounds in Intelligence Infrastructure Hell of a move by Armada, stepping into the limelight as a priority team leader in the U.S. SI Exports Program. The whole gig is under the Department of Commerce's belt, pushing the frontier of America's Super Intelligence (SI) technology to buddies across the globe. It's like watching the next big blockbuster unfold...

Continue Reading
Intel Faces Class Action Over Alleged Securities Fraud

Updated Category News Views 122

Intel's Legal Predicament: Decoding the Lawsuit Saddle up, folks, because Intel (NASDAQ: INTC) has found itself tangled in legal vines again. This ain't their first rodeo, and probably won't be their last. We're looking at a hefty class action lawsuit rallying on claims that Intel misled investors with optimistic yarns about their health. SBS Law, waving the litigation...

Continue Reading
Lake Ridge's Strong Quarter Meets a Book Value Hit

Updated Category News Views 26

An $8.25-per-share securities markdown is the splinter in an otherwise sturdy third-quarter report from Lake Ridge Bancorp. The bank earned $9.8 million, or $4.97 per common share, for the quarter ended September 30, 2026. That is up from $9.0 million, or $4.59 per share, in the prior quarter and $7.7 million, or $3.94 per share, a year earlier. Those are not flimsy...

Continue Reading

Top 5 Most Recently Viewed Articles

T-Mobile US: A Decade of Impressive Stock Growth Revealed

Updated Category News Views 142

T-Mobile US and Its Remarkable Growth Journey T-Mobile US (NASDAQ: TMUS) has shown exceptional growth over the last decade. With an annualized return rate of 20.05%, the company has outpaced the broader market by 8.22%. As of the latest information available, T-Mobile's market capitalization stands at an impressive $269.40 billion, highlighting its substantial position...

Continue Reading
Analysts Adjust TFI International's Forecasts After Q3 Report

Updated Category News Views 67

TFI International Reports Weaker-Than-Expected Q3 Earnings After the market closed on a recent Monday, TFI International (NYSE: TFII) announced its quarterly earnings figures, which unfortunately fell below expectations. The company reported earnings of $1.60 per share, compared to analyst predictions of $1.78 per share. In addition, TFI International's quarterly revenue...

Continue Reading
C3.ai Investors Face Class Action Amidst Poor Financial Results

Updated Category News Views 179

C3.ai Class Action Overview The Portnoy Law Firm is stepping forward to represent investors of C3.ai, Inc. as a class action develops. This legal move comes after concerning preliminary financial results announced by the company. Investors who purchased securities of C3 during the specified class period are encouraged to engage with the firm. Details of the Legal Class...

Continue Reading
21st.BIO Seeks EU Nod for Precision Fermentation Tech

Updated Category News Views 172

Is Precision Fermentation Europe's Next Big Bet? Here we go again with another tech trying to revolutionize the food industry, and this time it's the Danish company 21st.BIO making strides in Europe. They've tossed their hat in the ring with an EU Novel Food application for BLG Essential+™, hoping to weave precision fermentation into the fabric of European food...

Continue Reading
Key Pfizer Executives Support Current Leadership Amid Challenges

Updated Category News Views 105

Support for Pfizer's Leadership from Former Executives In a recent statement, former Pfizer executives, Ian Read and Frank D'Amelio, clarified their stance regarding the ongoing campaign by activist investor Starboard Value. They emphasized that they will not be engaging with Starboard, which has been advocating for changes within the pharmaceutical giant to enhance its...

Continue Reading